IDS Media Coverage

Dr. Larry Corey emphasized that “Thanks to broad U.S. investment, HIV research has opened the door to breakthroughs and treatments for diseases far beyond HIV/AIDS.”

Dr. Steve Pergam noted that federal advisory committees that evaluate vaccines “are the envy of most countries in how we address these policies and how we’ve done this. These are people that have spent their lives working on vaccines.”

Dr. Steve Pergam noted that federal advisory committees that evaluate vaccines “are the envy of most countries in how we address these policies and how we’ve done this. These are people that have spent their lives working on vaccines.”

Dr. Keith Jerome explained how dormant herpes infections can emerge “from this hiding place in the nerves... reactivate themselves and come back out, transmit to a new person or they can cause visible or sometimes painful lesions.”

Dr. Keith Jerome explained how dormant herpes infections can emerge “from this hiding place in the nerves... reactivate themselves and come back out, transmit to a new person or they can cause visible or sometimes painful lesions.”

Dr. Larry Corey talked about the evolution of COVID noting, “The effects that the early vaccination had have long worn off, and the virus has escaped from them. The hope is double boosting will transfer your immunity.”

Drs. Keith Jerome and Marius Walter discussed their Nature Communications study on gene editing for herpes. Jerome explained his hope for a herpes cure: “You don’t ever have to worry about this virus again.”

Fred Hutch patient Kaley Karaffa and Dr. Josh Hill explained how being immunocompromised impacts daily life. Karaffa said, “I had to become cautious about who I saw, the activities I was involved in and even the kind of food I ate.”

Dr. Larry Corey recommended everyone eligible for the COVID vaccine update get one. He said, “When we look at people who are currently hospitalized, they haven’t been boosted for a long time.”

Ro Yoon and Dr. Larry Corey shared perspectives on HIV research, activism and public fatigue. Yoon emphasized the importance of keeping HIV “relevant to an audience that might not be aware of the long, hard history of activism.”

Dr. Keith Jerome discussed his team’s progress in developing a gene therapy for herpes simplex virus. He said, “There’s not a cure yet that everybody can go out and get, but we’re getting closer to a cure.”

Dr. Keith Jerome described how his team’s herpes cure research could help people who want to be cured of their infection: “What we want to do is offer a tool that says if this really matters to you, we can help make your life better.”

Dr. Chris Johnston described next steps for work published in Nature with Dr. Susan Bullman: “Because this bacterium is so intimately associated with cancers, it raises the question, ‘can we harness this?’ That’s something we’re very interested in.”

Dr. Susan Bullman explained a new Nature study she co-authored with Dr. Chris Johnston and how a specific subtype of bacterium helps tumor cells hide from therapies: “It acts like a cloak.” Many medical and health news outlets also covered the study.

Dr. Josh Hill pointed out the need for preventive COVID-19 therapies. 

Dr. David Fredricks, a microbiome researcher, provided expert commentary on vaginal microbiota transplantation.

Fred Hutch virologist Dr. Keith Jerome provided expert commentary about the second person who reportedly has been cured of HIV.

Fred Hutch virologist Dr. Keith Jerome provided context around news of the second person who reportedly has been cured of HIV. He commented, “Now there’s not one, but two people that others living with HIV can look toward for encouragement.”

Dr. Keith Jerome is featured in a story of research progress in treating herpes. He explains how his work with the gene editing tool – a class of enzymes called meganucleases – is showing more success in getting rid of the virus. 

Fred Hutch researcher Drs. Keith Jerome, Hans-Peter Kiem and Michael Louella, who coordinates the research group’s Community Advisory Board, provide expert comments on the importance of community engagement in HIV research. 

Fred Hutch researcher Dr. Steve Pergam is featured as GeekWire’s ‘Geek of the Week’. Dr. Pergam is an associate member of the Vaccine and Infectious Disease Division at Fred Hutch. 
 

Fred Hutch researcher Dr. Steve Pergam comments on cannabis use among cancer patients.

This article features a recent study by Fred Hutch Drs. Dan Reeves and Josh Schiffer that shows that a majority of the HIV-infected cells that persist in HIV-infected individuals even during suppressive antiretroviral therapy (ART) originate from cellular proliferation, not viral replication.

Dr. Keith Jerome, a virologist at Fred Hutch, co-authored a 2016 study about gene editing in herpes-infected mice. “His is the first study to show that gene-editing technology can reach the latent virus in a nerve cell, and the first to use that technology to damage some of the virus’ DNA,” according to a Smithsonian.com article on this and other efforts to combat the virus in humans.

Profile of Dr. Larry Corey and his research on how immunotherapy could be used to attack HIV and other viruses

Article about a $2.6 million grant from Gilead Sciences to Dr. Larry Corey for HIV-cure research

Second in a two-part series about Fred Hutch's HIV vaccine research in South Africa quotes Dr. Larry Corey and Julie McElrath, among others

Second in a two-part series about Fred Hutch's HIV vaccine research in South Africa quotes Dr. Larry Corey and Julie McElrath, among others

Quotes Dr. David Fredricks, a microbiologist at the Hutch, in an article about how the vaginal microbiome might contribute to HIV risk

Article covers upcoming HIV Vaccine Trials Network large-scale trial, set to begin later this year, and quotes Dr. Larry Corey, president and director emeritus at Fred Hutch and principal investigator of the HVTN

Editorial by Fred Hutch HIV vaccine researcher and Director Emeritus Dr. Larry Corey and Nobel laureate Dr. David Baltimore of the California Institute of Technology

Fred Hutch virologist Dr. Larry Corey was interviewed about being featured in a VICE documentary on HBO, "Countdown to Zero," about the search for an HIV vaccine and cure.

Quotes Fred Hutch HIV vaccine researcher Dr. Larry Corey